January 2008 Volume 4, Issue 1

Volume 4, Issue 1 | January 2008

January 2008

In this Issue

Global News

Drug Discovery News Placeholder Image

Expansion in the East

MPI Research forms joint venture with Medicilon in Shanghai
Drug Discovery News Placeholder Image

BMS provides strategy, productivity update

Bristol-Myers Squibb Co. outlined an in-depth review of its business and research and development operations
Drug Discovery News Placeholder Image

Eisai to acquire MGI Pharma

Eisai Co. Ltd. and MGI Pharma Inc.recently unveiled a merger agreement
Drug Discovery News Placeholder Image

Argenta Discovery announces collaboration with Antisoma

Argenta Discovery Ltd. announced that it entered into a fee-for-service collaboration with Antisoma plc

Research & Development

Drug Discovery News Placeholder Image

Stemming the spread of cancer

GSK and OncoMed enter alliance for antibody-based oncology therapies that target cancer stem cells
Drug Discovery News Placeholder Image

Novartis taps MorphoSys

Ten-year program to develop therapeutic antibody pipeline is valued at up to $1 billion.
Drug Discovery News Placeholder Image

Heart-stopping research news

A second FDA-approved tyrosine kinase inhibitor shows cardiotoxicity
Drug Discovery News Placeholder Image

Vaccine venture

New institute in Switzerland looks to target HIV, TB and malaria
Drug Discovery News Placeholder Image

It’s only natural for GSK, Galapagos

Companies pair up on natural products for new anti-infectives
Drug Discovery News Placeholder Image

BioSeek initiates systems biology compound evaluation collaboration with UCB

BioSeek will apply its BioMAP Systems to evaluate a number of UCB compounds across several target classes

Genomics & Proteomics

Drug Discovery News Placeholder Image

The power of protein

Oxford Genome Sciences partners with Amgen to leverage its OGAP cancer protein database
Drug Discovery News Placeholder Image

Catching the bugs

NIAID-funded protein structure effort helps deCODE attack emerging diseases
Drug Discovery News Placeholder Image

The mouse that roared

Taconic Farms gets “complete offering” by purchasing a majority stake in company that genetically engineers mice
Drug Discovery News Placeholder Image

Snip judgment

Studies link SNPs to myeloma risk, therapy response
Drug Discovery News Placeholder Image

Right at the heart of the matter

Beckman Coulter CVD collaboration to boost diagnostics platform

Automation & Instrumentation

Drug Discovery News Placeholder Image

Genetic analysis portfolio push

USB acquisition would accelerate Affymetrix’s development of new genetic analysis tools
Drug Discovery News Placeholder Image

Clicking into place

Invitrogen expands its IP in the area of click chemistry
Drug Discovery News Placeholder Image

Collaborators love company

Asynt, Grant Instruments work together first, then form Uniqsis
Drug Discovery News Placeholder Image

Capital idea

HBIO sells bulk of capital equipment lines to Digilab
Drug Discovery News Placeholder Image

Going with the flow (cytometers)

Beckman Coulter launches Q-Check quality certification

Informatics

Drug Discovery News Placeholder Image

All fired up

Equinox launches Phyre software as Web-based pay-per-use service
Drug Discovery News Placeholder Image

Opening some eyes

ChemZoo online database brings in OpenEye software
Drug Discovery News Placeholder Image

Coming together as one

Golden Helix and Progeny integrate their products
Drug Discovery News Placeholder Image

WGHA work spawns new Golden Helix app

The result is a whole genome homozygosity association (WGHA)—and new Golden Helix software.
Drug Discovery News Placeholder Image

French lab deploys Luxid to facilitate discovery

TEMIS recently announced a strategic software and services agreement with Laboratoires Fournier

New Products

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue